Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q1 2016 · 10-Q
Revenue—
Net Income-$3.57M-$3.57MN/M vs Q1 2015 EPS Diluted-$0.78-$0.78N/M vs Q1 2015 Operating Income-$1,851,647N/M Operating Cash Flow-$1,774,933N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,789,546N/M ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end